Meperidine is not recommended for the management of chronic pain.
When used for acute pain (in patients without renal or CNS disease),
treatment should be limited to 48 hours and doses should not exceed 600
[CRCL >50 ml/min]: Usual doses. Limit therapy to 48hr and do not exceed
600 mg/24 hours.
[10-50 ml/min]: Avoid use. Note: Repeated use in renal impairment
should be avoided due to potential accumulation of neuroexcitatory
metabolite normeperidine. Alternatively, cautiously administer 75% of
normal dose and limit therapy to 24-48hr. Also, daily dose should not
exceed 400-450 mg/24 hours.
[<10 ]: Avoid use. Note: Repeated use in renal impairment should be
avoided due to potential accumulation of neuroexcitatory metabolite
normeperidine. Alternatively, cautiously administer 50% of normal dose
and limit therapy to 24hr. Also, daily dose should not exceed 200-300
National Institutes of Health, U.S. National Library of Medicine,
DailyMed Database. Provides access to the latest drug monographs submitted to the
Food and Drug Administration (FDA). Please review the latest applicable package insert for
additional information and possible updates. A local search
option of this data can be found here.
The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical
judgment. Neither GlobalRPh Inc. nor any other party involved in the
preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material.PLEASE READ THE DISCLAIMER
BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU
AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read